0
0
Read Time:10 Second
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled “Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %